Positron emission tomography molecular imaging-based cancer phenotyping.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 35417604.
- Also identified by DOI 10.1002/cncr.34228 and PMC identifier 9324101.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
During the past several decades, numerous studies have provided insights into biological characteristics of cancer cells and identified various hallmarks of cancer acquired in the tumorigenic processes. However, it is still challenging to image these distinctive traits of cancer to facilitate the management of patients in clinical settings. The rapidly evolving field of positron emission tomography (PET) imaging has provided opportunities to investigate cancer's biological characteristics in vivo. This article reviews the current status of PET imaging on characterizing hallmarks of cancer and discusses the future directions of PET imaging strategies facilitating in vivo cancer phenotyping.
Medical subject headings
- Neoplasms
- Positron-Emission Tomography